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Rat plasmaAbstract Sildenaﬁl citrate (SIL) is used in the treatment of erectile dysfunction and other chronic
disorders. For the pharmacokinetic investigation of SIL we developed a simple and sensitive
method for the estimation of SIL in rat plasma by reverse phase high-performance liquid chroma-
tography (RP-HPLC). The drug samples were extracted by liquid–liquid extraction with 300 ll of
acetonitrile and 5 ml of diethyl ether. Chromatographic separation was achieved on C18 column
using methanol:water (85:15 v/v) as mobile phase at a ﬂow rate of 1 ml/min and UV detection at
230 nm. The retention time of SIL was found to be 4.0 min having a separation time less than
5 min. The developed method was validated for accuracy, precision, linearity and recovery. Linear-
ity studies were found to be acceptable over the range of 0.1–6 lg/ml. The method was successfully
applied for the analysis of rat plasma sample for the application in pharmacokinetic study, drug
interaction, bioavailability and bioequivalence.
ª 2012 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Sildenaﬁl citrate, 1-[4-ethoxy-3-(6,7-dihydro-1-methyl-7-oxo-
3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)phenylsulfonyl]-4
methylpiperazine, is primarily indicated in the treatment of
erectile dysfunction (Vardi and Nini, 2007). It acts by inhibit-
ing cGMP-speciﬁc phosphodiesterase type 5, an enzyme that
promotes degradation of cGMP, which regulates the blood
ﬂow in the penis. The chemical structure of SIL is shown in
Fig. 1.
Figure 1 Chemical structure of SIL.
Table 1 Results of accuracy studies.
Sr. No. Nominal
concentration
(lg/ml) SIL
Recovered
amount
(lg/ml) SIL
Accuracy
(%) SIL
01 0.2 0.195 97.5
02 0.4 0.390 97.5
03 0.6 0.598 99.6
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the human plasma and biological samples. Methods such as
high-performance liquid chromatography (HPLC) have been
reported for the determination of SIL separately in biological
samples. Gas chromatography–mass spectrometry (GC/MS)
(Saisho et al., 2001), micellar electrokinetic chromatography
(Nevado et al., 2002), liquid chromatography–mass spectrom-
etry (LC/MS) (Weinmann et al., 2001; Dumestre-Toulet et al.,
2002) as well as liquid chromatography–tandem mass spec-
trometry (LC/MS/MS) (Eerkes et al., 2002; Kim et al., 2003;
Wang et al., 2005) methods have also been reported. Liquid
chromatography–mass spectrometry and liquid chromatogra-
phy–tandem mass spectrometry (LC/MS/MS) are expensive
and thus unavailable in many laboratories. High-performance
liquid chromatographic methods with UV detection have been
reported for the simultaneous determination of SIL and its
active metabolite (Hyland et al., 2000; Cooper et al., 1997;
Jeong et al., 2001; Liaw and Chang, 2001; Guermouchea and
Bensalah, 2006).
2. Experimental
2.1. Instrumentation
A double beam UV–vis spectrophotometer, model UV-2401
PC (Japan) with 10 mm matched quartz cell was used.
The HPLC instrument consisted of thermo separation
product quaternary gradient equipped with a pump spectra
system P-4000 having an inline membrane degasser,
detector was a UV–vis detector belonging to spectra system
UV 1000 and Rheodyne 9725 injector with 20 ll loop. All
the data were processed using Data Ace software. Separation
was achieved using a Prontosil C18 stationary phase
(150 · 4.6 mm i.d. 5 lm particle size) and the analytical
column was protected by a Phenomenex C18 guard column
(4 · 2.0 mm, i.d.).2.2. Materials and reagents
Sildenaﬁl citrate was donated by Ajanta Pharmaceuticals Pvt.
Ltd. All the reagents and chemicals used were of AR analytical
and HPLC grade. Methanol (Spectrochem) and water (Loba-
chem) used were of HPLC grade.
2.3. Chromatographic conditions
All determinations were carried out at room temperature. The
isocratic separation of compounds was carried out by using
mobile phase consisting of methanol:water (85:15 v/v). The
ﬂow rate was maintained at 1 ml min1. The volume of injec-
tion was 20 ll. The mobile phase was ﬁltered through
0.45 lm membrane ﬁlter and degassed by ultrasoniﬁcation.
2.4. Preparation of standard solutions
2.4.1. Sildenaﬁl citrate stock and working solutions
The stock solution of SIL was prepared by dissolving 10 mg in
100 ml of methanol and further dilutions were prepared in
methanol to obtain the working solution of SIL in the range
of 0.1–6 lg/ml.
2.5. Preparation of sample
Plasma samples were stored at 20 C and allowed to thaw at
roomtemperaturebeforeprocessing. Inbrief, to 100 ll of plasma,
100 ll aliquot of working standard solution of SIL was added in
polypropylene centrifuge tubes and thenwereadded300 ll of ace-
tonitrile and 5 ml of diethyl ether.Then tubeswere centrifuged for
10 min at 3000 rpm. The clear supernatant layer was transferred
intoanother conical glass tube andorganic layer completely evap-
orated at room temperature. After evaporation the remaining
things were dissolved inmobile phase. Resultant samples were in-
jected in developed chromatographic conditions.
2.6. Application of the assay
The above method was successfully applied for the pharmaco-
kinetic studies of SIL citrate in rats. Sprague–Dawley rats
(200–250 g) were housed with free access to food and water.
The rats were fasted overnight with free access to water before
administration of drugs. After a single oral administration of
2.5 mg/kg of SIL, 0.5 ml of blood samples were collected from
the retro orbital plexus sinus at 0.5, 1, 2, 4, 6, 12 and 24 h time-
points. Plasma was separated by centrifugation and stored at
20 C until analysis. Aliquots of 0.1 ml serum samples were
processed and analyzed for SIL concentrations.
The pharmacokinetic parameters were calculated with a
non-compartmental model using Kinetica TM Soft-ware (ver-
sion 4.4.1 Thermo Electron Corporation, USA). Each value is
expressed as mean ± SD.
3. Results and discussion
3.1. Method validation
3.1.1. Selectivity and speciﬁcity
Blank plasma was studied for endogenous interference. A rep-
resentative chromatogram of the plasma blank is shown in
Figure 2 HPLC trace of SIL using ultraviolet detection at 230 nm. (a) Blank plasma sample; (b) quality control standard (5 lg/ml).
Table 2 Results of precision studies (inter-day and intra-day).
Sr. No. Concentration of drug solution (lg/ml) Inter-day precision Intra-day precision
Peak area SIL % RSD Peak area SIL % RSD
1 0.2 29.3 ± 0.52 2.09 28.5 ± 0.45 2.01
2 0.4 56.54 ± 0.66 2.04 57.24 ± 0.66 2.03
3 0.8 205.43 ± 0.60 0.92 203.13 ± 0.45 0.98
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observed. Fig. 2b shows the chromatograms of calibration
standard containing 5 lg/ml of SIL in plasma.
3.1.2. Linearity and limit of quantitation
Linear calibration curves with correlation coefﬁcients greater
than 0.9999 were obtained over the concentration range of
0.1–6 lg/ml for SIL in plasma. The co-efﬁcient of regression
i.e., r2 = 0.9996 for SIL. The results had shown that withinTable 3 The percentage extraction recovery of measurement
of SIL from plasma.
Nominal concentration
(lg/ml)
Mean % recovery
GLIM SIL
1 91.2 89.3
5 86.4 88.5
10 89.7 89.4the concentration range indicated there was an excellent corre-
lation between peak area ratio and each concentration of SIL.Figure 3 Mean serum concentration–time proﬁle of SIL after
oral administration of 2.5 mg/kg of SIL in rats.
Table 4 The main pharmacokinetic parameters of mean drug serum concentration time curve (mean ± SD, n= 6) of SIL in rats after
single oral administration of 2.5 mg/kg of SIL.
Drugs AUCo-t (lg h/ml) AUC 0–1 (lg h/ml) Cmax (lg) Tmax (h) Kel T1/2 (h)
SIL 2.19 ± 0.052 0.5 ± 0.02 0.8 ± 0.05 1 h 0.10 ± 0.01 6.93
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tion was analyzed with an accuracy of ±15% and a co-
efﬁcient of variation of <15%, 0.16 lg/ml for SIL in plasma.
3.1.3. Accuracy
Accuracy studies were performed for SIL in terms of recovery
studies. For this 0.2, 0.4 and 0.6 lg/ml of both drugs in plasma
were injected and % recovery and % RSD were calculated.
(See, Table 1).
3.1.4. Precision
Inter-day and intra-day precision studies were done by injecting
three serial dilutions in developed chromatographic conditions
(n= 6). For precision studies 0.2, 0.4 and 0.8 lg/ml were in-
jected (n= 6). Peak areaswere calculated for%RSDvalues, re-
sults for inter-day and intra-day precision are shown in Table 2.
3.1.5. Extraction recovery
Extraction recovery of SIL was determined by comparing peak
areas obtained from extracted plasma samples with those
found by extracting blank matrices through the extraction pro-
cedure and spiking with a known amount of SIL. The results
showed that the mean extraction recoveries of SIL were
>85% at concentrations of 1.0, 5.0, and 10.0 lg/ml, respec-
tively (Table 3). Different organic extraction solvents were
evaluated in the experiment, including methanol, acetonitrile,
chloroform and diethyl ether. Diethyl ether and acetonitrile
combination proved to be the most efﬁcient in extracting
SIL from plasma and had a small variation in extraction recov-
eries over the concentration range.
Averaged for six measurements at each concentration level
(n= 6);
%recovery ¼ ðresponse of extracted spikeÞ
ðresponse of post-extracted spikeÞ  1 100:3.2. Application of the analytical method in pharmacokinetic
studies
The described method was applied to a pharmacokinetic study
in rats. After a single oral administration of SIL (2.5 mg/kg) to
rats, plasma concentrations were determined over a period of
24 h after administration. The mean serum concentration–time
curve after an oral dose of SIL (2.5 mg/kg) is shown in Fig. 3
and the main pharmacokinetic parameters are summarized in
Table 4. The Cmax of SIL detected in the rats was 2.19 lg/
ml, and the Tmax was 4 h.
4. Conclusion
In the present study a simple, accurate, and precise method
was developed for the estimation of SIL by RP-HPLC. Thedeveloped method was simple employing water and not a
buffer as component of mobile phase. The developed meth-
od was short with elution of SIL less than 5 min and speciﬁc
with no interferences of blank matrix interfering with the
quantiﬁcation of SIL. The developed method was applied
successfully for pharmacokinetic studies of SIL in rats.
The applicability of method suggests its further application
for bioequivalence, bioavailability and drug interaction
studies.
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